INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

SAMLYN CAPITAL, LLC's Holding History (CIK: 0001421097)

Note: Option positions (PUT/CALL) are excluded.

Q2 2019
Shares 226,628 Value ($000) $18,033 Avg Close — Range —